Key Northern Blotting Market Players:
- Thermo Fisher Scientific (USA)
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Rad Laboratories (USA)
- GE Healthcare (USA/UK)
- Merck KGaA (Germany)
- Agilent Technologies (USA)
- Takara Bio Inc. (Japan)
- Promega Corporation (USA)
- Roche Diagnostics (Switzerland)
- Abcam plc (UK)
- Sigma-Aldrich (Merck Subsidiary, USA/DE)
- BioVision Inc. (USA)
- OriGene Technologies (USA)
- Jena Bioscience GmbH (Germany)
- GenScript Biotech (USA/China)
- Fujifilm Wako Pure Chemical Corp. (Japan)
- Bio Basic Inc. (Canada)
- Axil Scientific (Singapore)
- Cell Signaling Technology (USA)
- CellBio (India)
- Vivantis Technologies (Malaysia)
The northern blotting market is actively expanding with the global leaders such as Thermo Fisher Scientific, Bio-Rad, and Merck KGaA accounting to hold 25.7% of the market. These mainly focus on the innovation of expanding the hybridization detection kits and RNA probe libraries. There is an increase in R&D financing programs, strategic alliances with academic institutions, and localization tactics in APAC regions such as Malaysia, Japan, and India. While companies in the U.S. place more emphasis on automation and high-throughput platforms, Japan companies like Takara Bio are utilizing next-generation blotting integrations.
Here is a list of key players operating in the global market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In 2025, the industry size of the northern blotting is assessed at 442.4 million.
Northern Blotting Market size was valued at USD 421.3 million in 2024 and is projected to reach USD 862.3 million by the end of 2037, registering around 5.8% CAGR during the forecast period, 2025 to 2037.
North America industry is anticipated to capture a significant share of 39.1% by 2037 due to the robust federal R&D investments.
The major players in the market are Thermo Fisher Scientific Inc., Labnet International, Inc., Qiagen, PerkinElmer Inc., Pall Corporation, Takara Bio Inc., Promega Corporation, New England Biolabs, and others.
